%0 Journal Article %A Joan SaldaƱa %A Caterina Scoglio %T Influence of heterogeneous age-group contact patterns on critical vaccination rates for herd immunity to SARS-CoV-2 %D 2021 %R 10.1101/2021.11.03.21265897 %J medRxiv %P 2021.11.03.21265897 %X Currently, several western countries have more than half of their population fully vaccinated against COVID-19. At the same time, some of them are experiencing a fourth or even a fifth wave of cases, most of them concentrated in sectors of the populations whose vaccination coverage is lower than the average. So, the initial scenario of vaccine prioritization has given way to a new one where achieving herd immunity is the primary concern. Using an age-structured vaccination model with waning immunity, we show that, under a limited supply of vaccines, a vaccination strategy based on minimizing the basic reproduction number allows for the deployment of a number of vaccine doses lower than the one required for maximizing the vaccination coverage. Such minimization is achieved by giving greater protection to those age groups that, for a given social contact pattern, have smaller fractions of susceptible individuals at the endemic equilibrium without vaccination, that is, to those groups that are more vulnerable to infection.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThe work of CS has been supported by the National Science Foundation under Grant Award IIS-2027336. JS has been partially supported by Grant No. PID2019-104437GB-I00 of the Agencia Estatal de Investigacion, Ministerio de Ciencia e Innovacion of the Spanish government.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data produced in the present study are available upon reasonable request to the authors %U https://www.medrxiv.org/content/medrxiv/early/2021/11/04/2021.11.03.21265897.full.pdf